Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients

Journal of Pathology

Volumn 192, Issue 1, 2000, Pages 52-57

  Warnakulasuriya, Saman ^a   Soussi, Thierry ^b   Maher, Rehana ^c   Johnson, Newell ^a   Tavassoli, Mahvash ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSERM   (France)

^c JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

Immunocytochemistry; Oral cancer; p53 Antibodies; Saliva; Serum

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN P53;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SALIVA LEVEL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AUTOANTIBODIES; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MOUTH NEOPLASMS; NEOPLASM PROTEINS; SALIVA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033828283     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH669>3.0.CO;2-C     Document Type: Article

References (28)

1. p53 Gene mutation: Software and database
2. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumours and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
3. Frequent p53 mutations in head and neck cancer
4. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma
5. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
6. p53 Mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability
7. Lack of molecular markers to predict malignant potential of oral precancer
8. Why is p53 protein stabilized in neoplasia? Some answers but many more questions!
9. p53 Overexpression in oral carcinoma: Divergence in different populations and some caveats in immunohistochemistry
10. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma
11. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
12. Prevalence of serum antibodies against the p53 tumour suppressor gene protein in various cancers
13. p53 Antibodies in patients with various types of cancer: Assay, identification and characterization
14. p53 Antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissue
15. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
16. p53 Antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity
17. Reproducibilty of two malignancy grading systems with reportedly prognostic value for oral cancer patients
18. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
19. The humoral response to oncoprotein p53 in head and neck cancer
20. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma
21. Anti-p53 antibodies in serum of smokers and head and neck cancer patients
22. Serum p53-antibodies in head and neck cancer
23. p53 Serum antibodies as prognostic indicator in head and neck cancer
24. p53 Autoantibodies in the sera of patients with oral squamous cell carcinoma
25. Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes
26. Circulating p53 antibodies as early markers of oral cancer: Correlation with p53 alterations
27. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas
28. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer